Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial

Context: Polycystic ovary syndrome (PCOS) is characterized by insulin resistance, compensatory hyperinsulinemia, increased prevalence of impaired glucose tolerance, and increased ovarian androgen biosynthesis. Objective: The aim of the study was to evaluate effects of pioglitazone on whole body insu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aroda, Vanita R., Ciaraldi, Theodore P., Burke, Paivi, Mudaliar, Sunder, Clopton, Paul, Phillips, Susan, Chang, R. Jeffrey, Henry, Robert R.
Format: Artigo
Idioma:Inglês
Publicat: The Endocrine Society 2009
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2646515/
https://ncbi.nlm.nih.gov/pubmed/18984667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2008-1133
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars